About us

Who we are BioArt Cultivation

Research and Development

We invest in ongoing research to understand the full therapeutic potential of cannabis, its interactions with other medications, and possible long-term effects. This research will lead to improved treatment guidelines and patient care.

Fields of activity

BioArt Cultivation uses a patented, recognized method to produce high-quality CBD products for wholesale and retail, including white-label solutions and the development of new projects in the field of edible CBD products.

Products

Our wide range of products includes CBD flowers, CBD cuttings, CBD oils, waxes, distillates, CBD isolates with controlled active ingredient content and medicinal THC.

Highest production standards according to GMP

Our technology is fully GMP-compliant, highly productive and delivers quality at the highest level - while being completely sustainable and waste-free.

Social Impacts

We consider the social and economic impacts of medical cannabis, including the creation of new jobs, potential tax revenue, and the effects on the community.

Projects & partnerships

Together we combine expertise, innovation and market knowledge. Bioart Cultivation works with strong partners such as TB Farming (strategy & production), Premium Chronic (own retail brand) and Metawise (marketing & business development)

Step by step to the Harvest

Long-term commitments

We are building a business model that does not rely solely on quick returns or a sale to a larger company. Instead, we are committed to creating a sustainable and long-term profitable operation.

Innovation and Adaptation

Continuous innovation and adaptability are crucial for us—whether in response to changes in the regulatory landscape, new scientific insights, or market demands.

These include:

Production plant

Our proprietary machines, patents and technologies form the foundation for our technological innovation.

GMP standard

Production according to pharmaceutical quality guidelines.

For every business idea

CBD products for wholesale, retail and white label projects

Since 2021

we set standards in quality and innovation

2021

CBD flower production

2022

Towards medical THC

2023

Expansion of the production plant

2024

Partnership with TB Farming

2025

Retail brand Premium Chronic

Social Responsibility

We take responsibility in society by building close relationships with local communities, both in terms of production and patient access. This should lead to a stronger sense of social responsibility and long-term trust.

Contact Us